null

Vopratelimab (Anti-ICOS) Biosimilar Antibody

SKU:
HDBS0012
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
ICOS
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-ICOS vopratelimab biosimilar mAb HDBS0012
  • Anti-ICOS vopratelimab biosimilar mAb HDBS0012
  • Anti-ICOS vopratelimab biosimilar mAb HDBS0012
€373
Frequently bought together:

Description

system_update_altDatasheet

Vopratelimab (Anti-ICOS) Biosimilar Antibody (HDBS0012)

The Anti-ICOS (Vopratelimab) Biosimilar MAb (HDBS0012) is a monoclonal antibody designed for research involving the ICOS protein, a key immune checkpoint molecule that plays a crucial role in regulating T-cell activation and immune response. This biosimilar antibody, with high specificity and affinity for ICOS, is optimized for use in various applications such as flow cytometry, immunohistochemistry, and ELISA.ICOS, also known as inducible T-cell co-stimulator, is a costimulatory molecule that is essential for T-cell activation and differentiation, making it a promising target for cancer immunotherapy and autoimmune disease research.

By blocking or activating ICOS signaling pathways, researchers can manipulate immune responses to enhance anti-tumor immunity or suppress autoimmune reactions.The Anti-ICOS (Vopratelimab) Biosimilar MAb (HDBS0012) provides a valuable tool for investigating the role of ICOS in immune regulation and disease pathogenesis. Its high specificity and reliability make it an ideal choice for studies exploring the therapeutic potential of targeting ICOS in various clinical settings. Order now to advance your research in immunology and oncology.